Previous studies have found that SOCS2 plays an anti-tumor role in breast cancer and colon cancer, while it acts as a pro-cancer factor in chronic myeloid leukemia. This evidence concerns the gene SOCS2 and chronic myelogenous leukemia, BCR-ABL1 positive.